Targeting Molecular Pathways in Intracranial Metastatic Disease
The discovery and clinical application of agents targeting pivotal molecular pathways in malignancies such as lung, breast, renal cell carcinoma, and melanoma have led to impressive improvements in clinical outcomes. Mutations in epidermal growth factor receptor (EGFR), and rearrangements of anaplas...
Main Authors: | Vyshak Alva Venur, Justine V. Cohen, Priscilla K. Brastianos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00099/full |
Similar Items
-
Editorial: Contemporary Management of Intracranial Metastatic Disease
by: Sunit Das, et al.
Published: (2019-08-01) -
Targeted Therapies for Brain Metastases from Breast Cancer
by: Vyshak Alva Venur, et al.
Published: (2016-09-01) -
Genetic Characterization of Brain Metastases in the Era of Targeted Therapy
by: Catherine H. Han, et al.
Published: (2017-09-01) -
The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
by: Matthew Dankner, et al.
Published: (2021-02-01) -
Brain Metastases from Colorectal Cancer: A Systematic Review of the Literature and Meta-Analysis to Establish a Guideline for Daily Treatment
by: Sophie Müller, et al.
Published: (2021-02-01)